Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors
Clinical trial NCT00765973 · COMPLETED
Trial details
- NCT number
- NCT00765973
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-10
- Primary completion
- 2010-06-30
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.